Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-24 @ 11:45 PM
NCT ID:
NCT04081051
Eligibility Criteria:
Inclusion Criteria:
* Patients presenting with fever with no focus/RTI:
* Children (6 months to \<12 years) and adolescents (12 years to less than 18 years old) of both sexes .
* Presenting with an acute febrile illness defined as temperature of \>37.5°C or history of fever within the last 7 days with no focus or suspected RTI.
* Parent/guardian providing written informed consent for their children if less than 18 years of age.
* Obtain assent for adolescent between 12 and less than 18 years old
* Willing to provide blood and other samples and adhere to study procedures explained in the consent forms following the protocol.
* Available and willing to return for follow-up visit at the health facility on day 7 (+/- 2 days).
Exclusion Criteria:
* o Children and adolescents from 6 months to less than 18 years old presenting with chronic febrile illness (fever lasting more than 7 days).
* Patients with acute febrile illness outside the allowed age range for the site.
* Severely ill patients requiring hospital admission or referral as assessed by the study clinicians.
* Anyone refusing consent to the study or not able to attend the health centre for follow-up (adults, the children of parents/guardians, or adolescents who refuse or are missed when asking for consent).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Maximum Age:
65 Years
Study:
NCT04081051
Study Brief:
Protocol Section:
NCT04081051